Why Don’t People with COVID-19 Symptoms Get Tested?
Mild symptoms, poor knowledge of nearby testing sites, and certain demographic factors have been identified as barriers to COVID-19 testing.
Tag: COVID-19 testing
All
Latest
All
Latest
Backed by Millions in Public and Private Cash, Rapid COVID Tests Are Coming to Stores Near You
Scientists and lawmakers agree that over-the-counter COVID-19 tests could allow desk workers to settle back into their cubicles and make it easier to reopen schools and travel.
All
Latest
LabCorp’s Pixel COVID-19 Test Now Authorized Direct-to-Consumer
LabCorp’s Pixel COVID-19 Test Home Collection Kit has been authorized for emergency use by the FDA -- the first COVID-19 direct-to-consumer (non-prescription) test system.
Will the New 15-minute COVID-19 Test Solve US Testing Problems?
On Aug. 26, the Food and Drug Administration granted an Emergency Use Authorization to a new rapid antigen test for COVID-19 called the BinaxNOW test.
Read More
New COVID-19 Assay Can Monitor Vaccine Responses
Leinco Technologies has developed a proprietary, fully validated assay: the COVID-19 ImmunoRank Neutralization MICRO-ELISA test.
Read More
Will the New 15-minute COVID-19 Test Solve US Testing Problems?
The Food and Drug Administration granted an Emergency Use Authorization to a new rapid antigen test for COVID-19 called the BinaxNOW test.
Read More
FDA Authorizes First COVID-19 Test Where Results Can Be Read Directly From Testing Card
The BinaxNOW COVID-19 Ag Card is the first antigen test where results can be read directly from the testing card, a similar design to some pregnancy tests.
Read More
FDA Authorized Six Additional COVID-19 Tests This Week
As of Aug 13, 2020, the FDA has now authorized 213 COVID-19 tests under emergency use authorizations.EUAs, including 174 molecular tests, 37 antibody tests, and 2 antigen tests.
Read More
FDA Authorizes GWU SARS-CoV-2 Test
The FDA issued an emergency use authorization for the GWU SARS-CoV-2 RT-PCR Test to George Washington University’s Public Health Laboratory.
Read More
FDA Authorizes ‘Pooled’ COVID-19 Testing for up to Four Samples
The FDA authorized a Quest Diagnostics COVID-19 test for “pooled” samples, allowing four people to be tested with one assay.
Read More
FDA Authorizes BD Veritor 15-min COVID-19 Antigen Test
The US FDA has authorized the BD Veritor Plus SARS-CoV-2 assay, a rapid, point-of-care, antigen test manufactured by Becton Dickinson.
Read More
FDA Revokes Authorization for Chembio Antibody COVID-19 Test
The US FDA revoked the emergency use authorization of the DPP COVID-19 IgM/IgG System, a SARS-CoV-2 antibody test from Chembio Diagnostic System Inc, due to performance concerns with the accuracy of the test.
Read More
FDA Authorizes First Sequencing-based Test for COVID-19
The US FDA issued an emergency use authorization for the Illumina COVIDSeq Test, the first COVID-19 diagnostic test utilizing next generation sequence technology.
Read More
CDC Develops Test to Detect Both COVID-19 and Influenza
The CDC is seeking emergency use authorization for a new diagnostic test that can simultaneously detect the SARS-CoV-2 coronavirus and the influenza virus.
Read More
False Negatives in Diagnostic Testing of COVID-19
Researchers at Johns Hopkins have found that the chance of a false negative COVID-19 result is greater than 1 in 5 and, at times, far higher. The researchers caution that the predictive value of the reverse transcriptase polymerase chain reaction test (RT-PCR), which may not always yield accurate results.
Read More